Oral transmucosal fentanyl citrate for the treatment of breakthrough pain

被引：0
|
作者：
Zarth, R.
Ehmer, M.
Sittig, H. -B.
机构：
[1] Univ Tubingen, Akad Lehrkrankenhaus, Zollernalb Klinikum, Anaesthesiol & Intens Med Abt, D-72336 Balingen, Germany
[2] Praxis Schemerztherapie & Palliativ Med, Freiburg, Germany
[3] Spezielle Schmerztherapie Palliativ Med, MVZ Buntenskamp, Geesthacht, Germany
来源：
SCHMERZ | 2007年 / 21卷 / 06期
关键词：
cancer-related pain; breakthrough pain; oral transmucosal fentanyl citrate; observational study;
D O I：
10.1007/s00482-007-0590-z
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
In a non-interventional study the efficacy and tolerability of oral transmucosal fentanyl citrate (OTFC) was studied in patients with opioid-treated cancer pain suffering from breakthrough pain. The prospective multicenter observational trial included 406 patients. For 3-4 months, efficacy of OTFC treatment for breakthrough pain was documented using a numerical analog pain intensity scale (NAS). Further, OTFC therapy was rated and adverse events were recorded. With application of oral transmucosal fentanyl citrate median pain intensity fell from NAS 8 points at the beginning to NAS 2 points at the end of the study. The median effective dosage was 400 g. Tolerability was rated as good or very good by 87.5% of the patients. Oral transmucosal fentanyl citrate is a safe and effective treatment for breakthrough pain in chronic cancer-related pain.
引用
收藏
页码：545 / 552
页数：8
相关论文
共 50 条
  • [41] Efficacy of Sublingual Fentanyl vs. Oral Morphine for Cancer-Related Breakthrough Pain
    Velazquez Rivera, Ignacio
    Munoz Garrido, Jose Carlos
    Garcia Velasco, Pilar
    Espana Ximenez de Enciso, Inmaculada
    Velazquez Clavarana, Lourdes
    ADVANCES IN THERAPY, 2014, 31 (01) : 107 - 117
  • [42] Formulation Selection and Pharmacokinetic Comparison of Fentanyl Buccal Soluble Film with Oral Transmucosal Fentanyl Citrate A Randomized, Open-Label, Single-Dose, Crossover Study
    Vasisht, Niraj
    Gever, Larry N.
    Tagarro, Ignacio
    Finn, Andrew L.
    CLINICAL DRUG INVESTIGATION, 2009, 29 (10) : 647 - 654
  • [43] Long-term efficacy and tolerability of intranasal fentanyl in the treatment of breakthrough cancer pain
    Sebastiano Mercadante
    Renato Vellucci
    Arturo Cuomo
    Claudio Adile
    Andrea Cortegiani
    Alessandro Valle
    Patrizia Villari
    Alessandra Casuccio
    Supportive Care in Cancer, 2015, 23 : 1349 - 1354
  • [44] A Randomized, Placebo-Controlled Study of a New Sublingual Formulation of Fentanyl Citrate (Fentanyl Ethypharm) for Breakthrough Pain in Opioid-Treated Patients With Cancer
    Novotna, Stanislava
    Valentova, Klara
    Fricova, Jitka
    Richterova, Eva
    Harabisova, Sarka
    Bullier, Francoise
    Trinquet, Francoise
    CLINICAL THERAPEUTICS, 2014, 36 (03) : 357 - 367
  • [45] Long-term efficacy and tolerability of intranasal fentanyl in the treatment of breakthrough cancer pain
    Mercadante, Sebastiano
    Vellucci, Renato
    Cuomo, Arturo
    Adile, Claudio
    Cortegiani, Andrea
    Valle, Alessandro
    Villari, Patrizia
    Casuccio, Alessandra
    SUPPORTIVE CARE IN CANCER, 2015, 23 (05) : 1349 - 1354
  • [46] Fentanyl Sublingual Spray for Breakthrough Pain in Cancer Patients
    Zeppetella G.
    Pain and Therapy, 2013, 2 (1) : 1 - 9
  • [47] An assessment of the safety, efficacy, and acceptability of intranasal fentanyl citrate in the management of cancer-related breakthrough pain: A pilot study
    Zeppetella, G
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2000, 20 (04) : 253 - 258
  • [48] Danish Pain Specialists' Rationales behind the Choice of Fentanyl Transdermal Patches and Oral Transmucosal Systems-A Delphi Study
    Jacobsen, Ramune
    Moldrup, Claus
    Christrup, Lona
    PAIN MEDICINE, 2009, 10 (08) : 1442 - 1451
  • [49] Tolerabilidad y efectividad del citrato de fentanilo oral transmucosa en el tratamiento a largo plazo del dolor irruptivo en pacientes oncológicos: estudio ECODIRSafety and efficacy of oral trans-mucosal fentanyl citrate in the long-term treatment of breakthrough pain in oncology patients: the ECODIR study
    Vicente Valentín Maganto
    Carlos Camps Herrero
    Joan Carulla Torrent
    Javier Cassinello Espinosa
    Javier Dorta Delgado
    Carlos Jara Sánchez
    José Andrés Moreno Nogueira
    Clinical and Translational Oncology, 2005, 7 (5) : 205 - 212
  • [50] Fentanyl Buccal Tablet for the Treatment of Breakthrough Pain: Pharmacokinetics of Buccal Mucosa Delivery and Clinical Efficacy
    Darwish, Mona
    Hamed, Ehab
    Messina, John
    PERSPECTIVES IN MEDICINAL CHEMISTRY, 2010, 4 : 11 - 21
12345